Pipeline Drives Orbis Medicines to Raise EUR 90 Million in Series A Funding Orbis Medicines, a leader in oral macrocycle drug discovery, has successfully closed a EUR 90 million Series A funding round, bringing the company’s total capital raised to…
Appoints Giancarlo Benelli as Head of Europe at BeiGene BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company set to rebrand as BeOne Medicines Ltd., appoints Giancarlo Benelli as Senior Vice President and Head of Europe, effective…
Novosound Unveils First Ultrasound Blood Pressure Monitor at CES 2025 Novosound, a groundbreaking company in ultrasound sensor development, is poised to make history at CES 2025 in Las Vegas by unveiling its ultrasound blood pressure monitoring technology. This marks a…
Foot & Ankle: Fusion Orthopedics Strategically Expands Reach Fusion Orthopedics USA, LLC (“Fusion”) has announced the successful expansion of its product portfolio with the acquisition of Metalogix External Fixation Systems. This transition, which includes Metalogix’s operations, distribution, and hospital accounts,…
Gene Therapy: JCR Pharmaceuticals and Modalis Advance Research JCR Pharmaceuticals Co., Ltd. (TOKYO:4552) and Modalis Therapeutics Corporation (TOKYO:4883) have announced a major advancement in their joint research program aimed at developing a novel gene therapy for central nervous system (CNS)…
Heart Disease Awareness Raised with Free Heart & Kidney Screenings in Macon Care Access, a health and research company, is offering residents of Macon, Georgia, the opportunity to participate in its Heart & Kidney Health Screening initiative. This program aims…
GeneDx Appoints Bryan Dechairo as Chief Operating Officer GeneDx (Nasdaq: WGS), a leader in advancing health outcomes through genomic insights, has announced the appointment of Bryan Dechairo as Chief Operating Officer (COO), effective immediately. In this newly created role, Dechairo…
Certification Achieved by ModMed for AI-Powered Scribe by ASTP/ONC ModMed®, a leading innovator in healthcare technology, announced that its electronic health records (EHR) platform, EMA®, has successfully achieved certification from the Assistant Secretary for Technology Policy/Office of the National Coordinator…
Therapies: PharmaEssentia Ensures Reliable Interferon Access PharmaEssentia (TWSE: 6446), a leading global biopharmaceutical company, has reaffirmed its commitment to ensuring robust and reliable access to critical interferon therapies, particularly in light of the reported global shortage of Pegasys® (peginterferon alfa-2a).…
Voom CEO Dr. Neal Blitz Guest Edits January 2025 Clinics in Podiatric Medicine Issue on MIS Voom™ Medical Devices, Inc. (“Voom”), a pioneering company revolutionizing minimally invasive foot and ankle surgery, is excited to announce that its Founder and CEO,…
